Neuromodulation in Cardiac Diseases

Total Page:16

File Type:pdf, Size:1020Kb

Neuromodulation in Cardiac Diseases NeuromodulationNeuromodulationNeuromodulation ininin CardiacCardiacCardiac Diseases:Diseases:Diseases: ClinicalClinicalClinical andandand MechanisticMechanisticMechanistic StudiesStudiesStudies VisceralVisceralVisceral Seminar.Seminar.Seminar. SeptemberSeptemberSeptember 14,14,14, 200920092009 MikeMikeMike JLJLJL DeJongsteDeJongsteDeJongste,,, MD,MD,MD, PhD,PhD,PhD, FESCFESCFESC UniversityUniversity MedicalMedical CenterCenter GroningenGroningen DeptDept ofof Cardiology,Cardiology, Thoraxcenter.Thoraxcenter. Groningen.Groningen. NetherlandsNetherlands onon behalfbehalf ofof thethe WorkingWorking GroupsGroups NeuroNeuro CardiologyCardiology WGNCWGNC !! (Insignificant)(Insignificant) disclosuresdisclosures - steering committee new study (Medtronic) - incidental member advisory group (St Jude Medical) WGNCWGNC ! Evolving indications in cardiac diseases - heart failure - arrhythmias - acute coronary syndromes ! Mechanisms of Action of SCS in angina WGNCWGNC EvolvingEvolving indication:indication: HeartHeart FailureFailure WGNCWGNC ! HautvastT = 9RWM, (following Szabo 3 monthsBM, DeJongste SCS); MJL,C Hooijschuur = 8 (3 months CAM, no LieSCS) KI, Staal MJ, Meyler WJ, Küthe RF, Zijlstra GJ. Influence of spinal cord stimulation on left ventricular function in patients with refractory angina pectoris. 2nd international Symposium on Heart Failure- mechanisms and management 1993, Geneva, Switzerland Hautvast R et al. 2nd Int. Symp. Heart Failure, 1993, Geneva, Switzerland WGNCWGNC Kujavic V et al. Eur Heart J 1993;14:1238-44 Pts 15 SCS; 64 (49-71) years with refractory AP Methods Echo at rest + following adenosine provocation Pts randomized to active SCS or withheld SCS Results control LVEF 44% ! 37% (p< 0.05) SCS LVEF 48% ! 44% (ns) WGNCWGNC TENS (NMES) in Heart Failure or COPD (Sillen MJ et al. Chest, 2009:136:44-61 {review}) Concl. NMES looks promising as a means of rehabilitating patients with CHF and COPD. WGNCWGNC Effect of Neuromodulation on echocardiographic indices Lopshire et al Circulation. 2009 Jul 28;120(4):286-94 WGNCWGNC EvolvingEvolving indication:indication: ArrhythmiasArrhythmias WGNCWGNC DOG X: no SCS DOG X: SCS pre-treatment occlusion SCS “on” release occlusion occlusion ventricular tachycardia 5 min. occlusion WGNCWGNC release occlusion NN == 2020 caninescanines xx 22 2020 SCSSCS ++ 2020 SCSSCS -- VT/VFVT/VF == 22 VT/VFVT/VF == 88 8th INS World Congress, Acapulco, 2007 WGNCWGNC Experimental studies: Neuromodulation & Arrhythmias (Issa ZF et al. Circulation, 2005: 111:3217-20) WGNCWGNC SCS + 5/22; SCS - 13/22 VT/VF Effect of neuromodulation on ventricular arrhythmias: phase 1 study Lopshire, JC et al. Circulation,2009;120:286-94 WGNCWGNC Antianginal Effects of Electrical Neuromodulation WGNCWGNC Indication:Indication: IschemicIschemic HeartHeart DiseasesDiseases ! Stable angina ! Acute coronary syndromes unstable angina myocardial infarction WGNCWGNC Health related quality of life (6 RCT; n = 129) SCS Control Std. Mean Difference Std. Mean Difference Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% CI IV, Random, 95% CI 1.3.1 SCS vs Active comparator ESBY 1998 15 27 45 18 40 45 50.9% -0.09 [-0.50, 0.33] SPiRiT 2006 29.8 12.3 31 24.7 14.1 29 49.1% 0.38 [-0.13, 0.89] Subtotal (95% CI) 76 74 100.0% 0.12 [-0.33, 0.58] Heterogeneity: Tau! = 0.05; Chi! = 1.95, df = 1 (P = 0.16); I! = 49% Test for overall effect: Z = 0.52 (P = 0.60) 1.3.2 SCS ON vs SCS OFF DeJongste, 1994 2.1 0.6 8 1.25 0.8 9 25.1% 1.13 [0.08, 2.18] Eddicks 2007 56.3 10 12 45.9 11 12 28.3% 0.96 [0.10, 1.81] Hauvast 1998 6.8 1 13 6.2 1.1 12 29.1% 0.55 [-0.25, 1.36] Lanza 2005 0.75 0.1 10 0.35 0.1 10 17.5% 3.83 [2.24, 5.42] Subtotal (95% CI) 43 43 100.0% 1.44 [0.37, 2.51] Heterogeneity: Tau! = 0.89; Chi! = 13.25, df = 3 (P = 0.004); I! = 77% Test for overall effect: Z = 2.64 (P = 0.008) -10 -5 0 5 10 Favours Control Favours SCS Meta analysis (Björreson et al. Pain,2008;140:501-8; WGNCWGNC Taylor & DeJongste. BMC Cardiovasc Disord,2009;9:13) Exercise capacity (7 RCTs; n = 140) SCS Control Std. Mean Difference Std. Mean Difference Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% CI IV, Random, 95% CI 1.1.1 SCS vs Active comparator SPiRiT 2006 7.3 3.5 32 7.3 3.8 33 48.5% 0.00 [-0.49, 0.49] ESBY 1998 92.2 33.7 53 99 28 47 51.5% -0.22 [-0.61, 0.18] Subtotal (95% CI) 85 80 100.0% -0.13 [-0.44, 0.18] Heterogeneity: Tau! = 0.00; Chi! = 0.46, df = 1 (P = 0.50); I! = 0% Test for overall effect: Z = 0.84 (P = 0.40) 1.1.2 SCS ON vs SCS OFF Jessurun 1999 14.6 3.2 12 15.3 3.4 12 21.9% -0.20 [-1.01, 0.60] Hauvast 1998 19 14 13 -0.2 17 12 20.7% 1.20 [0.33, 2.06] Eddicks 2007 394 55 12 337 55 12 20.9% 1.00 [0.14, 1.86] Lanza 2005 22 10 10 12 7.5 10 19.1% 1.08 [0.13, 2.04] DeJongste 1994 827 138 8 694 67 9 17.4% 1.19 [0.13, 2.24] Subtotal (95% CI) 55 55 100.0% 0.82 [0.25, 1.38] Heterogeneity: Tau! = 0.20; Chi! = 7.90, df = 4 (P = 0.10); I! = 49% Test for overall effect: Z = 2.84 (P = 0.005) -4 -2 0 2 4 Favours control Favours SCS Meta analysis (Björreson et al. Pain,2008;140:501-8; Taylor & DeJongste. BMC Cardiovasc Disord,2009;9:13) WGNCWGNC (Chronic)(Chronic) IschemiaIschemia ofof MyocyteMyocyte Release of pain (& inflammatory) mediators (adenosine, bradykinin, lactate, prostaglandins) High Nociceptor Threshold SCS Low Threshold Spinal cord WGNCWGNC Sensitization Antiischemic Effects of Electrical Neuromodulation WGNCWGNC Börjesson M et al. Pain, 2008, 140: 501-8 Antiischemic effect of neuromodulation is “associated with a reduction in myocardial oxygen consumption” 1 + “secondary to reduced myocardial ischaemia” 2 1. Br Heart1988;59:56-61. “ST depression " at comparable workload” 2. Br Med J, 1993;307:477-80. “Improved lactate metabolism” WGNCWGNC AntiischemicAntiischemic EffectsEffects ofof SCSSCS inin StableStable AnginaAngina (Summary)(Summary)(Summary) # exercise capacity (quality of life measurements; exercise stress testing) " ST-segment depression & " lactate production (exercise stress testing; ambulatory ECG; R.A. pacing) #coronary flow in non-stenotic coronary artery (coronary blood flow studies) altering coronary perfusion ! opening collaterals ! redistributes O2 supply ! decreases O2 demand (PET and flow studies) WGNCWGNC Indication:Indication: IschemicIschemic HeartHeart DiseasesDiseases ! Stable angina ! Acute coronary syndromes myocardial infarction unstable angina WGNCWGNC AntiischemicAntiischemic EffectsEffects ofof ElectricalElectrical NeuromodulationNeuromodulation inin AcuteAcute CoronaryCoronary SyndromeSyndrome A Historic Perspective by Braunwald E. Reflections on efforts to reduce ischemic myocardial damage Cardiovasc Res 2002:56:332-8 “...the observation in 1968 that ST-segment # were reduced in a patient with an AMI during carotid sinus nerve stimulation, supported the suggestion that myocardial ischemia was not necessarily irreversible.” (idea was based on Z Busse W, Stubinger HG. Z Gesamte Exp Med 1951) WGNCWGNC Börjesson M et al. TENS in unstable angina pectoris Coron Artery Dis, 1997:8:543-550 ! Hypothesis - Tens may have favorable effects on silent ischemia (predictor of outcome) ! Methods - Continuous vector ECG - 30 patients randomized TENS (14) or Control (16) ! Results * TENS well tolerated, not interfered with standard treatment * TENS group - decrease in # silent ischemia periods (p = 0.02) ; - decrease in duration silent ischemia periods (p =0.01); - ns effect on painful periods (small #) - cardiac enzyme (ns), however, 4 AMI in placebo (1†) vs 1 in TENS WGNCWGNC DeVries J et al. Neuromodulation, 2007;10:345-8 Chronic Unstable Refractory Angina (Braunwald class IIIb) • 6.6 ± 4.2 year follow-up • TENS remains effective in 78% • 16 out of 27 still alive WGNCWGNC DeVries J et al. J of Electrocardiology, 2007;40:522-6 38 STEMISTEMI pts cross-overcross-over randomized postpost PCIPCI 15 min 15 min Group 1 Active TENS Sham TENS ST _ 0.65 _ 0.55 =15% 0.55 _ 0.50 = 9% (p =0.02) (p =0.01) 15 min 15 min Group 2 Sham TENS Active TENS ST _ 0.37 _ 0.33 =11% 0.33 _ 0.28 =15% (ns) (p =0.01) WGNCWGNC Ardell J et al. Pre-emptive, Spinal Cord Stimulation mitigates Myocardial Infarction via Cardiac Adrenergic Neurons. AJP: Heart & Circulation, 2007;292:H311 -----------------Spinal Cord Stimulation---------------------- Reactive Pre-emptive $-Blocker $+% Blocker IWGN WGNCWGNC In search of a common final pathway to explain the mechanisms of action of electrical neuromodulation in patients with cardiac diseases WGNCWGNC Nervous & Humoral Loops Somato-sensory cortex (psychosocial) Thalamus (coordinating integrating) Autonomic Spinothalamic tract Nervous System Dorsal horn neurons & Dorsal Root ganglion SCSSCS Cardiac sensory fibers (extrinsic cardiac ganglia) Intrinsic Cardiac Neurons (intrinsic cardiac ganglia) WGNCWGNC International Working Group on Neurocardiology CANADA SWEDEN J. Andrew Armour, MD, PhD Bengt Linderoth, MD, PhD Cardiovascular Neurosurgeon Physiologist NETHERLANDS GERMANY Mike J.L. DeJongste, MD, PhD Heinz Theres, MD Cardiologist Cardiologist UNITED STATES Robert D. Foreman, PhD Neurophysiologist Jeffrey L. Ardell, PhD Pharmacologist Philip B. Adamson, MD IWGNWGNCWGNC IWGN Cardiologist Intrinsic Cardiac Nervous System aggregates of cardiac neurons and neural interconnections that modulate cardiac function Right Atrial Ganglionated Plexus IWGNWGNCWGNC SuppressionSuppression ofof IntrinsicIntrinsic CardiacCardiac NerveNerve ActivityActivity ((CardiovascCardiovasc ResRes 2000;47:3672000;47:367 && AutonAuton NeurosciNeurosci 20022002 10;95:7110;95:71 CAO SCS 60 A 50 1000 * 600 40 Imp/min * * 0 IMP/ 30 MIN SCS B 20 1000 10 600 Imp/min * * * 0 0 0 2 5 10 15 20 25 30 35 40 45 MINUTES Conclusion: SCS obtunds ICN activity, IWGNIWGNWGNCWGNC even during myocardial ischemia electrico-nervousnervous && humoralhumoral remodelingremodeling suppression of nociceptive " electroanalgesic transmission effect stabilizing activity of Intrinsic" antiarrhythmic Cardiac Nervous System effect? SCS Improved at T1-T2 (C1-2?, T4?) Cardiac release of neuropeptides " _1 adrenergic function (e.g.
Recommended publications
  • Cardiac Sympathectomy and Spinal Cord Stimulation Attenuate Reflex-Mediated Norepinephrine Release During Ischemia Preventing Ventricular Fibrillation
    Cardiac sympathectomy and spinal cord stimulation attenuate reflex-mediated norepinephrine release during ischemia preventing ventricular fibrillation Jeffrey L. Ardell, … , J. Andrew Armour, Kalyanam Shivkumar JCI Insight. 2019. https://doi.org/10.1172/jci.insight.131648. Research In-Press Preview Cardiology Neuroscience Rationale: Reflex-mediated sympathoexcitation is central to the pathogenesis of arrhythmias and heart disease; neuraxial modulation can favorably attenuate these cardiac reflexes leading to cardioprotection. Objective: The purpose of this study was to define the mechanism by which cardiac neural decentralization and spinal cord stimulation (SCS) reduces ischemia-induced ventricular fibrillation (VF) and sudden cardiac death (SCD) by utilizing direct neurotransmitter measurements in the heart. Methods and Results: Direct measurement of norepinephrine (NE) levels in the left ventricular (LV) interstitial fluid (ISF) by microdialysis in response to transient left anterior descending coronary artery occlusion (CAO: 15 min) in anesthetized canines. Responses were studied with: (i) intact neuraxis and were compared to those in which the (ii) intrathoracic component of the cardiac neuraxis (stellate ganglia),(iii) the intrinsic cardiac neuronal (ICN) system were surgically delinked from the central nervous system versus (iv) subjects with intact neuraxis subjected to pre-emptive SCS (T1-T3 spinal level). With an intact neuraxis, animals with exaggerated NE-ISF levels in response to CAO were at increased risk for VF and SCD. During CAO there was a 152% increase in NE level when the entire neuraxis was intact compared to 114% following intrathoracic neuraxial decentralization (removal of the stellates) and 16% increase following ICN decentralization, when the entire heart and ICN was delinked from the other levels of the neuraxis.
    [Show full text]
  • 'Voodoo' Death Revisited: the Modern Lessons of Neurocardiology†
    KEYNOTE ADDRESS MARTIN A. SAMUELS, MD, DSc (hon), FAAN, MACP* Neurologist-in-Chief and Chairman Department of Neurology Brigham and Women’s Hospital Professor of Neurology Harvard Medical School Boston, MA ‘Voodoo’ death revisited: The modern lessons of neurocardiology† n 1942, Walter Bradford Cannon published a personal danger or threat of injury; (7) after danger is remarkable paper entitled “‘Voodoo’ Death,”1 in over; and (8) reunion, triumph, or happy ending. which he recounted anecdotal experiences, largely Common to all is that they involve events impossible I from the anthropology literature, of death from for the victim to ignore and to which the response is fright. These events, drawn from widely disparate parts overwhelming excitation, giving up, or both. of the world, had several features in common. They were In 1957, Carl Richter reported on a series of experi- all induced by an absolute belief that an external force, ments aimed at elucidating the mechanism of such as a wizard or medicine man, could, at will, cause Cannon’s “voodoo” death.3 Richter studied the length demise and that the victim himself had no power to alter of time domesticated rats could swim at various water this course. This perceived lack of control over a power- temperatures and found that at a water temperature of ful external force is the sine qua non for all the cases 93º these rats could swim for 60 to 80 minutes. recounted by Cannon, who postulated that death was However, if the animal’s whiskers were trimmed, it caused “by a lasting and intense action of the sym- would invariably drown within a few minutes.
    [Show full text]
  • Neuromodulation Therapies for Intractable Angina: a Review
    Research Article Clinics in Surgery Published: 06 Apr, 2021 Neuromodulation Therapies for Intractable Angina: A Review Patel S1* and Mammis A2 1Department of Neurosurgery, Rutgers New Jersey Medical School, USA 2Department of Neurosurgery, New York University School of Medicine, USA Abstract Background: Transcutaneous Electrical Nerve Stimulation (TENS) and Spinal Cord Stimulation (SCS) are neuromodulation therapies that have shown to be effective as treatments for the care of Intractable Angina. In addition, Stellate Ganglion Block (SGB), although not considered a neuromodulation therapy, has proven to be a successful interventional therapy. Objective: With the minimal research studying the use of neuromodulation therapies to treat intractable angina, this review looks to summarize the pre-existing data published and see which neuromodulation therapies have proven to be successful in treating patients with Intractable Angina. Methods: A literature search was done on PubMed, Google Scholars, and ResearchGate to discover 3 different neuromodulation therapies that have shown to be effective in the treatment of intractable angina. Factors that were searched for include safety, complications, and the application of the neuromodulation therapy. Results: 12 articles were analyzed with 3 three different neuromodulation therapies. For Spinal Cord Stimulation (SCS), 19 patients were implanted for SCS and the results found that both admission rate and hospital stay time were lower after SCS (0.97 vs. 0.27) and (8.3 days vs. 2.5 days). For Transcutaneous Electrical Nerve Stimulation (TENS), results have shown reduced frequency of anginal attacks, and increased work capacity. For Stellate Ganglion Block (SGB), the mean pain relief duration was 3.5 weeks. SBG has proven to be an alternative neuromodulation invasive strategy for the treatment of intractable angina.
    [Show full text]
  • Book of Abstracts
    11rH CONGRESS OF THE INTERNATIONAL SOCIETY FOR AUTONOMIC NEUROSCIENCE BOOK OF JULY 25 - 27, 2019 I LOS ANGELES, CALIFORNIA ABSTRACTS Confocal microscopic image of a mouse dorsal root ganglion labeled with a multicolor adeno-associated virus-based approach. Neurons within the dorsal root ganglia are critical for processing sensory information from visceral organs. Image courtesy of Pradeep Rajendran and Rosemary Challis of the Shivkumar Lab at UCLA and the Gradinaru Lab at Caltech. isan2019.org 11rH CONGRESS OF THE INTERNATIONAL SOC IETY FOR AUTONOMIC NEUROSCIENCE JULY 25 - 27 , 2019 LOS ANGELES , CALIFORNIA TABLE OF CONTENTS ORAL PRESENTATIONS 4 POSTER PRESENTATIONS THURSDAY JULY 25 60 FRIDAY JULY 26 82 SATURDAY JULY 27 112 TECHNOLOGY SHOWCASE 142 AUTHOR INDEX 154 11TH CONGRESS OF THE INTERNATIONAL SOCIETY FOR AUTONOMIC NEUROSCIENCE JULY 25-27, 2019 | LOS ANGELES CALIFORNIA 2 ORAL PRESENTATIONS isan2019.org ORAL PRESENTATIONS SESSION: ENTERIC NEURAL CIRCUITRY IN MOUSE AND HUMAN COLON: THE CHANGING FACE OF MORPHOLOGY, FUNCTION AND THERAPEUTIC LEADS JULY 25, 2019 | 9:20 AM–11:20 AM ISAN19.003 ISAN19.005 REFINING ENTERIC NEURAL CIRCUITRY BY VISUALIZING THE HUMAN ENTERIC NERVOUS SYSTEM QUANTITATIVE MORPHOLOGY, TRANSCRIPTOMICS IN 3-DIMENSIONS: NEW WAYS TO THINK ABOUT AND FUNCTION IN MICE AUTONOMIC NEUROPATHY Marthe Howard, Andrea L. Kalinoski, Joseph F. Margiotta, Kahleb Graham1, Silvia Huerta Lopez1, Rajarshi Sengupta1, Samantha Mckee, Kalina Venkova, Alexander Hristov Archana Shenoy1, Christina M. Wright1, Sabine Schneider1, Michael D. Feldman2, Emma E. Furth3, Federico University of Toledo Health Sciences, Neurosciences, Toledo, 2 4 1 UNITED STATES OF AMERICA Valdivieso , Amanda Lemke , Benjamin J. Wilkins , Marthe Howard5, Pierre A. Russo6, Edward J.
    [Show full text]
  • Human Consciousness: the Universal Heart Based Resonant Frequencies and the Massive Ecosystems Hierarchy
    ISSN: 2641-1911 DOI: 10.33552/ANN.2020.09.000709 Archives in Neurology & Neuroscience Mini Review Copyright © All rights are reserved by Abdullah A Alabdulgader Human Consciousness: The Universal Heart Based Resonant Frequencies and the Massive ecosystems Hierarchy Abdullah A Alabdulgader* Congenital Cardiologist & Invasive Electro physiologist, Prince Sultan Cardiac Center, Saudi Arabia *Corresponding author: Abdullah Al Abdulgader, Congenital Cardiologist & Received Date: October 15, 2020 Invasive Electro physiologist, Prince Sultan Cardiac Center, P.O.Box 9596, Hofuf, Al-Ahsa 31982, Saudi Arabia. Published Date: November 02, 2020 Mini Review the 21st century, are still not investigated in an integral had became evident, the dawn of which emerged in respectful Few scientific dilemmas in the beginning of the third decade of publications from KOO and scientific collaborates research. There is compelling scientific and rational evidence to convince scientific comprehensive approach compatible with the era scientific communities that the nature of consciousness involves dynamics advances. Human Consciousness, its origin, nature and the delicate inside the skull but essentially much beyond it in extreme symphony orchestrating its execution remains at the top of the list adopted is based on holistic perspective and understanding of dimensions between the skull and the sky. The approach we of the elusive sciences of the human history. Intuitively, our ancestors refer to the human heart as the seat of soul and the center human consciousness
    [Show full text]
  • Heart Rate Variability in Children and Adolescents with Cerebral Palsy—A Systematic Literature Review
    Journal of Clinical Medicine Review Heart Rate Variability in Children and Adolescents with Cerebral Palsy—A Systematic Literature Review Jakub S. G ˛asior 1,* , Antonio Roberto Zamunér 2 , Luiz Eduardo Virgilio Silva 3 , Craig A. Williams 4 , Rafał Baranowski 5, Jerzy Sacha 6,7 , Paulina Machura 8, Wacław Kochman 9 and Bo˙zenaWerner 10 1 Faculty of Medical Sciences and Health Sciences, Kazimierz Pulaski University of Technology and Humanities, 26-600 Radom, Poland 2 Departamento de Kinesiología, Universidad Católica del Maule, 3480112 Talca, Maule, Chile; [email protected] 3 Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo 14049-900, Brazil; [email protected] 4 Children’s Health and Exercise Research Centre, Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter, St Luke’s Campus, Exeter EX1 2LU, UK; [email protected] 5 Department of Heart Rhythm Disorders, National Institute of Cardiology, 04-628 Warsaw, Poland; [email protected] 6 Faculty of Physical Education and Physiotherapy, Opole University of Technology, 45-758 Opole, Poland; [email protected] 7 Department of Cardiology, University Hospital in Opole, University of Opole, 45-401 Opole, Poland 8 Department of Gynaecological Endocrinology, Medical University of Warsaw, 00-950 Warsaw, Poland; [email protected] 9 Clinical Department of Cardiology at Bielanski Hospital, National Institute of Cardiology, 01-809 Warsaw, Poland; [email protected] 10 Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-793-199-222 Received: 18 March 2020; Accepted: 13 April 2020; Published: 16 April 2020 Abstract: Cardiac autonomic dysfunction has been reported in patients with cerebral palsy (CP).
    [Show full text]
  • Sympathetic Tales: Subdivisons of the Autonomic Nervous System and the Impact of Developmental Studies Uwe Ernsberger* and Hermann Rohrer
    Ernsberger and Rohrer Neural Development (2018) 13:20 https://doi.org/10.1186/s13064-018-0117-6 REVIEW Open Access Sympathetic tales: subdivisons of the autonomic nervous system and the impact of developmental studies Uwe Ernsberger* and Hermann Rohrer Abstract Remarkable progress in a range of biomedical disciplines has promoted the understanding of the cellular components of the autonomic nervous system and their differentiation during development to a critical level. Characterization of the gene expression fingerprints of individual neurons and identification of the key regulators of autonomic neuron differentiation enables us to comprehend the development of different sets of autonomic neurons. Their individual functional properties emerge as a consequence of differential gene expression initiated by the action of specific developmental regulators. In this review, we delineate the anatomical and physiological observations that led to the subdivision into sympathetic and parasympathetic domains and analyze how the recent molecular insights melt into and challenge the classical description of the autonomic nervous system. Keywords: Sympathetic, Parasympathetic, Transcription factor, Preganglionic, Postganglionic, Autonomic nervous system, Sacral, Pelvic ganglion, Heart Background interplay of nervous and hormonal control in particular The “great sympathetic”... “was the principal means of mediated by the sympathetic nervous system and the ad- bringing about the sympathies of the body”. With these renal gland in adapting the internal
    [Show full text]
  • US Medical, Scientific, Patient and Civic Organization Funding Report: Fourth Quarter 2009
    US Medical, Scientific, Patient and Civic Organization Funding Report: Fourth Quarter 2009 Recipient Name Program / Project Description Payment Amount (USD) AARON DIAMOND AIDS RESEARCH CENTER Annual Diamond Fundraising Event $10,000 ACCELERATED CURE PROJECT Dance to Cure MS 2009 Event $1,000 ACCORDIA GLOBAL HEALTH FOUNDATION General operating support for the Global Health Fellows capacity building program $1,000 ACCORDIA GLOBAL HEALTH FOUNDATION General operating support for the Infectious Diseases Institute, Kampala, Uganda $1,800,000 ACTION CENTER FOR EDUCATION AND COMMUNITY HELP Project: Action PACT Health Education Literacy Plan $300,000 DEVELOPMENT ADDICTIONS CARE FOUNDATION Annual Family Chocolate Fundraising Event $1,000 ADELPHI EDEN HEALTH COMMUNICATIONS, LLC Pfizer Epilepsy Scholarship Program $75,000 AFRICAN AMERICAN HEALTH COALITION 7th Annual Wellness Within Reach Walk $5,000 AID FOR AIDS INTERNATIONAL My Hero Fundraising Event $20,000 AIDS CARE SERVICE, INC. General operating support for the Global Health Fellows capacity building program $1,000 AIDS PROJECT OF CENTRAL IOWA General operating support for technology to increase advocacy capabilities $1,500 AIDS PROJECT OF CENTRAL IOWA Positive Iowans Taking Charge Educational Support $500 ALABAMA PRIMARY HEALTH CARE ASSOCIATION 24th Annual Conference $1,500 ALASKA PHARMACISTS ASSOCIATION Tobacco: Global Problem $10,000 ALBERT EINSTEIN COLLEGE OF MEDICINE 2010 Educational Initiative: Rural Oncology Science and Practice $150,000 ALBERT EINSTEIN COLLEGE OF MEDICINE Best Practices
    [Show full text]
  • The Intrinsic Cardiac Nervous System and Its Role in Cardiac Pacemaking and Conduction
    Journal of Cardiovascular Development and Disease Review The Intrinsic Cardiac Nervous System and Its Role in Cardiac Pacemaking and Conduction Laura Fedele * and Thomas Brand * Developmental Dynamics, National Heart and Lung Institute (NHLI), Imperial College, London W12 0NN, UK * Correspondence: [email protected] (L.F.); [email protected] (T.B.); Tel.: +44-(0)-207-594-6531 (L.F.); +44-(0)-207-594-8744 (T.B.) Received: 17 August 2020; Accepted: 20 November 2020; Published: 24 November 2020 Abstract: The cardiac autonomic nervous system (CANS) plays a key role for the regulation of cardiac activity with its dysregulation being involved in various heart diseases, such as cardiac arrhythmias. The CANS comprises the extrinsic and intrinsic innervation of the heart. The intrinsic cardiac nervous system (ICNS) includes the network of the intracardiac ganglia and interconnecting neurons. The cardiac ganglia contribute to the tight modulation of cardiac electrophysiology, working as a local hub integrating the inputs of the extrinsic innervation and the ICNS. A better understanding of the role of the ICNS for the modulation of the cardiac conduction system will be crucial for targeted therapies of various arrhythmias. We describe the embryonic development, anatomy, and physiology of the ICNS. By correlating the topography of the intracardiac neurons with what is known regarding their biophysical and neurochemical properties, we outline their physiological role in the control of pacemaker activity of the sinoatrial and atrioventricular nodes. We conclude by highlighting cardiac disorders with a putative involvement of the ICNS and outline open questions that need to be addressed in order to better understand the physiology and pathophysiology of the ICNS.
    [Show full text]
  • Neurocardiology. Physiopathological Aspects and Clinical Implications
    BOOK REVIEW Neurocardiology. Physiopathological aspects and clinical implications by Ricardo J. Gelpi and Bruno Buchholz. @ 2018 Elsevier, Spain, S: L: U; ISBN: 978-84-9113-155-7; eISBN 978-84-9113-203-5 “Books are the quietest and most constant of friends; they that 4,128 of these works date from the last 5 years (3). are the most accessible and wisest of counselors, As the authors point out, Neurocardiology. Physio- and the most patient of teachers.” pathological aspects and clinical implications, is the CHARLES W. E LIOT (1834-1926) first book in Spanish that provides a global view on this specialty, ranging from basic aspects to clinical “I always imagined paradise as a kind of library” manifestations, making it a comprehensive resource JORGE L. BORGES (1899-1986) of great value for this emerging discipline. This book is addressed to researchers, residents and physicians trained in cardiology, neurology, internal Medicine, in- Neurocardiology. Pathophysiological aspects and clini- tensive care medicine, anesthesiology, cardiovascular cal implications, a book by Ricardo J. Gelpi and Bruno surgery and neurosurgery, It will also be of interest to Buchholz, published in 2018, is presented in a volume professionals from other related areas. “ of 365 pages and 20 color illustrations. Sixty-five coau- The work is organized in 29 chapters. The first is thors of national and international relevance collabo- introductory and refers to the history of neurocardiol- rated in its edition. ogy. Chapters 2 to 8 analyze anatomical, physiological As
    [Show full text]
  • Cardiac Neurotransmission Imaging*
    CONTINUING EDUCATION Cardiac Neurotransmission Imaging* Ignasi Carrio´ Department of Nuclear Medicine, Hospital Sant Pau, Barcelona, Spain though no structural heart disease can be shown by tradi- Cardiac neurotransmission imaging with SPECT and PET allows tional morphologic and functional investigations. In such a in vivo assessment of presynaptic reuptake and neurotransmit- situation, evaluation of abnormalities of the cardiac nerves, ter storage as well as of regional distribution and activity of cardiac ganglia, and neurotransmission process may be clin- postsynaptic receptors. In this way, the biochemical processes ically relevant. In the United States, approximately 300,000 that occur during neurotransmission can be investigated in vivo at a micromolar level using radiolabeled neurotransmitters and sudden cardiac deaths occur each year, and almost 20% of receptor ligands. SPECT and PET of cardiac neurotransmission them are in patients without evidence of coronary artery characterize myocardial neuronal function in primary cardio- disease (2). Nuclear medicine is currently the only imaging neuropathies, in which the heart has no significant structural modality with sufficient sensitivity to offer in vivo visual- abnormality, and in secondary cardioneuropathies caused by ization of cardiac neurotransmission at a micromolar level. the metabolic and functional changes that take place in different Such a unique capability has great diagnostic potential and diseases of the heart. In patients with heart failure, the assess- currently allows noninvasive classification of dysautono- ment of sympathetic activity has important prognostic implica- tions and will result in better therapy and outcome. In diabetic mias, characterization of pathologic myocardial substrate in patients, scintigraphic techniques allow the detection of auto- arrhythmogenic cardiomyopathies, and assessment of neu- nomic neuropathy in early stages of the disease.
    [Show full text]
  • Neuromodulation Approaches for Cardiac Arrhythmias: Recent Advances
    Current Cardiology Reports (2019) 21: 32 https://doi.org/10.1007/s11886-019-1120-1 INVASIVE ELECTROPHYSIOLOGY AND PACING (EK HEIST, SECTION EDITOR) Neuromodulation Approaches for Cardiac Arrhythmias: Recent Advances Veronica Dusi1,2 & Ching Zhu 2 & Olujimi A. Ajijola2 Published online: 18 March 2019 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review This review aims to describe the latest advances in autonomic neuromodulation approaches to treating cardiac arrhythmias, with a focus on ventricular arrhythmias. Recent Findings The increasing understanding of neuronal remodeling in cardiac diseases has led to the development and improvement of novel neuromodulation therapies targeting multiple levels of the autonomic nervous system. Thoracic epidural anesthesia, spinal cord stimulation, stellate ganglion modulatory therapies, vagal stimulation, renal denervation, and interventions on the intracardiac nervous system have all been studied in preclinical models, with encouraging preliminary clinical data. Summary The autonomic nervous system regulates all the electrical processes of the heart and plays an important role in the pathophysiology of cardiac arrhythmias. Despite recent advances in the clinical application of cardiac neuromodulation, our comprehension of the anatomy and function of the cardiac autonomic nervous system is still limited. Hopefully in the near future, more preclinical data combined with larger clinical trials will lead to further improvements in neuromodulatory treatment for heart rhythm disorders. Keywords Cardiac autonomic nervous system . Ventricular arrhythmias . Neuromodulation . Stellate ganglion Introduction feedback loops that enable autonomic control of cardiac func- tion. The entire autonomic nervous system (ANS) aims to The heart is richly innervated by afferent as well as sympa- maintain cardiac homeostasis in the face of environmental thetic and parasympathetic efferent nerves.
    [Show full text]